Dispersyn Gerrit 4
4 · Phio Pharmaceuticals Corp. · Filed Nov 20, 2019
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Common stock, $0.0001 par value
2019-11-18$0.10/sh+350,000$35,000→ 827,817 total
Footnotes (1)
- [F1]Includes shares of common stock underlying unvested restricted stock units.